Table 3 The summary results for other adverse events

Paraplegia

TEVAR versus OMT

6

2.06 (0.88–4.80)

0.096

25.0

0.246

OSR versus OMT

4

3.60 (2.20–5.89)

< 0.001

0.0

0.492

OSR versus TEVAR

4

0.90 (0.55–1.47)

0.681

0.0

0.489

Myocardial infraction

TEVAR versus OMT

6

1.20 (0.60–2.39)

0.603

50.2

0.074

OSR versus OMT

2

2.13 (0.17–27.26)

0.562

38.2

0.203

OSR versus TEVAR

4

2.76 (1.64–4.65)

< 0.001

0.0

0.811

Mesenteric ischemia

TEVAR versus OMT

2

3.96 (0.40–39.46)

0.241

64.4

0.094

OSR versus OMT

2

3.25 (0.17–62.38)

0.435

70.3

0.067

OSR versus TEVAR

2

1.14 (0.36–3.56)

0.827

0.0

0.453

Limb ischemia

TEVAR versus OMT

1

13.00 (4.33–39.06)

< 0.001

-

-

OSR versus OMT

1

7.80 (2.39–25.49)

0.001

-

-

OSR versus TEVAR

1

0.59 (0.17–1.98)

0.389

-

-

Reintervention

TEVAR versus OMT

7

0.92 (0.43–1.94)

0.825

82.4

< 0.001

OSR versus OMT

2

0.46 (0.08–2.74)

0.391

0.0

0.523

OSR versus TEVAR

5

0.30 (0.10–0.89)

0.030

0.0

0.529

Respiratory failure

TEVAR versus OMT

2

2.11 (0.37–12.09)

0.401

81.0

0.022

OSR versus OMT

2

2.22 (0.05–89.95)

0.672

92.8

< 0.001

OSR versus TEVAR

6

2.19 (1.73–2.76)

< 0.001

0.0

0.419

Bleeding

TEVAR versus OMT

2

3.65 (2.40–5.55)

< 0.001

0.0

0.838

OSR versus OMT

1

9.54 (6.57–13.85)

< 0.001

-

-

OSR versus TEVAR

5

1.88 (1.33–2.67)

< 0.001

17.6

0.303